Ataxia with loss of Purkinje cells in a mouse model for Refsum disease.

Proc Natl Acad Sci U S A

Academic Medical Center, Department of Clinical Chemistry (Laboratory of Genetic Metabolic Diseases), Emma's Children Hospital, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.

Published: November 2008

Refsum disease is caused by a deficiency of phytanoyl-CoA hydroxylase (PHYH), the first enzyme of the peroxisomal alpha-oxidation system, resulting in the accumulation of the branched-chain fatty acid phytanic acid. The main clinical symptoms are polyneuropathy, cerebellar ataxia, and retinitis pigmentosa. To study the pathogenesis of Refsum disease, we generated and characterized a Phyh knockout mouse. We studied the pathological effects of phytanic acid accumulation in Phyh(-/-) mice fed a diet supplemented with phytol, the precursor of phytanic acid. Phytanic acid accumulation caused a reduction in body weight, hepatic steatosis, and testicular atrophy with loss of spermatogonia. Phenotype assessment using the SHIRPA protocol and subsequent automated gait analysis using the CatWalk system revealed unsteady gait with strongly reduced paw print area for both fore- and hindpaws and reduced base of support for the hindpaws. Histochemical analyses in the CNS showed astrocytosis and up-regulation of calcium-binding proteins. In addition, a loss of Purkinje cells in the cerebellum was observed. No demyelination was present in the CNS. Motor nerve conduction velocity measurements revealed a peripheral neuropathy. Our results show that, in the mouse, high phytanic acid levels cause a peripheral neuropathy and ataxia with loss of Purkinje cells. These findings provide important insights in the pathophysiology of Refsum disease.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2584743PMC
http://dx.doi.org/10.1073/pnas.0806066105DOI Listing

Publication Analysis

Top Keywords

phytanic acid
20
refsum disease
16
loss purkinje
12
purkinje cells
12
ataxia loss
8
acid phytanic
8
acid accumulation
8
peripheral neuropathy
8
acid
6
phytanic
5

Similar Publications

In this study, environmentally friendly flame retardants capable of efficient flame retardancy at low concentrations in wood were developed. Urea-formaldehyde (UF) resin and guanidinium azole (GZ)-phytate (PA)-copper hydroxide (Cu(OH)) flame-retardant resin coating blends were prepared using urea, formaldehyde, 3,5-diamino-1,2,4-triazole (GZ), phytanic acid (PA), and copper hydroxide (Cu(OH)). Employing dioctyl phthalate as the plasticizer and tannic acid as the curing agent, a three-stage reaction was performed to obtain the desired UF-GZ/PA/Cu as a bio-based flame retardant.

View Article and Find Full Text PDF

Alpha-methylacyl-CoA-racemase (AMACR) deficiency (MIM#604489) is a peroxisomal disorder resulting in the accumulation of pristanic acid, dihydroxycholestanoic acid (DHCA), and trihydroxycholestanoic acid (THCA), with variable clinical features and age of onset from infancy to late adulthood. The purpose of this report is to define clinical variations and follow-up data in AMACR deficiency emphasizing treatment with a review of cases reported in the literature. Here, four patients, from two families, diagnosed with AMACR deficiency and showing phenotypic heterogeneity are presented.

View Article and Find Full Text PDF
Article Synopsis
  • Refsum disease is a rare genetic disorder affecting lipid metabolism, leading to the buildup of phytanic acid and resulting in symptoms like ataxia, neuropathy, and hearing loss, with potential cardiac issues developing later in life.
  • A case study presented a 38-year-old man who experienced acute heart failure due to dilated cardiomyopathy, confirmed by high levels of phytanic acid, illustrating that cardiac problems are common in advanced Refsum disease.
  • Management options for Refsum disease include dietary restrictions on phytanic acid and lipid apheresis to alleviate symptoms and improve patients' quality of life.
View Article and Find Full Text PDF
Article Synopsis
  • The study aims to investigate the molecular effects of the PHYH:c.678+5G>T variant, which has conflicting reports in the ClinVar database and appears with a low frequency in the South Asian population.
  • Researchers recruited patients with retinitis pigmentosa from Moorfields Eye Hospital and Buenos Aires, who had biallelic PHYH variants, and analyzed their blood samples for RNA sequencing.
  • Results showed that the variant significantly affects splicing in the PHYH gene, indicating a pathogenic classification, suggesting that patients with this genotype should be tested for phytanic acid levels due to varying presentations of the disease.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!